Ring Indenter Scleral Self-Indentation Versus Assistant-Assisted Indentation for Basal Vitrectomy in Primary Rhegmatogenous Retinal Detachment: A Retrospective Cohort Study.
Pan, Liu … Pan
Retina·May 29, 2026
A ring indenter scleral self-indentation technique demonstrated equivalent safety and efficacy to conventional assistant-assisted indentation for basal vitrectomy in primary rhegmatogenous retinal detachment repair, with comparable reattachment rates and visual outcomes.
Factors associated with persistent vision loss in eyes with diabetic macular edema and non-proliferative diabetic retinopathy after lost-to-follow-up.
Zafar, Momenaei … Hsu
Retina·May 29, 2026
Among diabetic macular edema patients who returned after being lost to follow-up for >6 months, approximately 27% had persistent vision loss ≥10 letters at 12 months despite resuming anti-VEGF treatment.
Inflammatory and Imaging Biomarkers in Treatment-Naïve Diabetic Macular Edema: Comparison with Irvine-Gass and Cataract Controls.
Demirel, Yanık … Özmert
Retina·May 26, 2026
Treatment-naïve diabetic macular edema (DME) showed distinct inflammatory profiles compared to Irvine-Gass syndrome, with lower aqueous cytokine levels and higher frequency of hyperreflective foci on OCT, suggesting early-stage disease characteristics.
Real-World Outcomes after Switch to Aflibercept 8 mg in Neovascular AMD: Twelve Months Follow-up on 654 Eyes.
Lee, Karunainathan … Cehofski
Retina·May 26, 2026
Switching plateau-phase neovascular AMD eyes to aflibercept 8 mg improved anatomical outcomes with 69% achieving dry maculae at 12 months and enabled treatment interval extension from 6.0 to 7.8 weeks, though with a slight decline in visual acuity.
Pathologic Myopia Globe Shape and Long-Term Prognosis.
Xiong, Tan … Wang
JAMA Ophthalmol·May 28, 2026
This 15-year prospective cohort study of 152 highly myopic eyes found that 3D eye shape, particularly nasally distorted and conical phenotypes, significantly predicts structural and functional deterioration including faster axial elongation, choroidal thinning, and myopic macular degeneration progression.
Atypical COQ2-Related Retinopathy in Identical Twins with Nephropathy Mimicking Intermediate Uveitis.
Gavric, Volk … Jaki Mekjavic
Ocul Immunol Inflamm·May 28, 2026
Identical twins with COQ2-related retinopathy presented with an atypical phenotype mimicking intermediate uveitis with cystoid macular edema, rather than the typical retinitis pigmentosa-like presentation, expanding the recognized spectrum of this genetic condition.
Preterm Infant Stress During Noncontact Handheld Optical Coherence Tomography and Contact Fundus Photography.
Li, Sarin …
JAMA Ophthalmol·May 28, 2026
Noncontact handheld OCT caused significantly less stress in preterm infants during ROP examinations compared to contact fundus photography, with lower pain scores, reduced changes in vital signs, and fewer adverse events.
Hydroxychloroquine in the treatment of sarcoidosis-associated uveitis and idiopathic uveitis.
Plavonil, Jacquot … El-Jammal
J Ophthalmic Inflamm Infect·May 28, 2026
Hydroxychloroquine demonstrated efficacy as a steroid-sparing agent in sarcoidosis-associated and idiopathic uveitis, with 55% of SAU and 40% of IdU patients achieving successful treatment at last visit while significantly reducing prednisone requirements.
Efficacy of Adalimumab Therapy for Non-Infectious Uveitis in Japanese Patients: Methotrexate Concomitance Across Different Uveitis Etiologies and the Effect of Dose Spacing.
Sakamoto, Hiyama … Harada
Ocul Immunol Inflamm·May 28, 2026
Adalimumab effectively controlled non-infectious uveitis in Japanese patients, achieving inactive disease in 61.5% at 12 months with significant steroid-sparing benefits, though etiology-dependent differences in methotrexate requirements and dose spacing outcomes were observed.
Beyond the Usual: A Case Series on Atypical Manifestations of HLA-B27 Uveitis.
Kene, Dutta Majumder … McCluskey
Ocul Immunol Inflamm·May 27, 2026
This retrospective case series of 9 patients demonstrates that HLA-B27-associated uveitis can present with severe vitritis and posterior segment involvement, challenging traditional diagnostic expectations and leading to potential misdiagnosis including endogenous endophthalmitis.
Ocular Inflammation as a Risk Factor for Anti-Adalimumab Antibodies in Patients with Autoimmune Diseases Treated with Adalimumab.
Elaraby, El-Feky … Nguyen
Ophthalmology·May 26, 2026
Ocular inflammation significantly increases the risk of developing anti-adalimumab antibodies (AAA) in patients with autoimmune diseases, with over 21% of adalimumab-treated patients developing these antibodies.
Fluocinolone Acetonide Versus Dexamethasone Intravitreal Implants for Non-Infectious Posterior-Segment Uveitis: 12-Month Real-World Outcomes.
Chen, Zhang … Song
Ocul Immunol Inflamm·May 26, 2026
In this real-world study of 117 eyes with non-infectious posterior uveitis, fluocinolone acetonide implants provided more sustained anatomical control with fewer injections compared to dexamethasone implants, but required greater IOP management.
Optical Coherence Tomography (OCT) Features of Inactive Multifocal Choroiditis with Panuveitis and Punctate Inner Choroidopathy (MFCPU/PIC) Lesions.
Trinco, Ferdeghini … Invernizzi
Am J Ophthalmol·May 25, 2026
This study identified Bruch's membrane disruption (94.7% vs 6.1% in controls) and inner retinal layer herniation (57.9% vs 4.3%) as highly characteristic OCT features that can help diagnose inactive MFCPU/PIC lesions when active inflammation is absent.
CD163+ Foamy Histiocytes in the Vitreous of a Patient with West Nile Virus-Associated Chorioretinitis.
Katzir, Abu Al-Halawa … Amer
Ocul Immunol Inflamm·May 25, 2026
This case report documents the first cytological evidence of CD163+ foamy histiocytes in vitreous humor of a patient with West Nile Virus-associated chorioretinitis, identified through diagnostic vitrectomy.
Comments on the methodology and data analysis in the treatment of choroidal metastasis with combined photodynamic therapy and bevacizumab compared with photodynamic therapy alone.
Lam & Au
Retina·May 29, 2026
Abstract not available — see full article for details.
Reply to Editor by Drs. Lam and Au regarding our article, "Treatment of Choroidal Metastasis with Combined Photodynamic Therapy and Bevacizumab and Comparison with Photodynamic Therapy Alone."1.
Aykut, Sezenoz … Demirci
Retina·May 29, 2026
Abstract not available — see full article for details.
Endophthalmitis, surgical complications, drug safety, adverse events
Postoperative Panophthalmitis in a Silicone Oil-Filled Eye: A Case Report and Review of the Literature.
AlTahan & AlHadlag
Ocul Immunol Inflamm·May 28, 2026
This case report documents the first reported instance of postoperative endophthalmitis progressing to panophthalmitis in a silicone oil-filled eye following pars plana vitrectomy, highlighting the rarity and poor outcomes of this complication.
Comparative Outcomes of Exogenous and Endogenous MRSA Vs MSSA Endophthalmitis.
Katragadda & Palestine
Ocul Immunol Inflamm·May 26, 2026
This retrospective study of 46 eyes found no significant differences in visual outcomes between MRSA and MSSA endophthalmitis, though exogenous cases had higher rates of enucleation/evisceration compared to endogenous cases.
Culture-proven endogenous endophthalmitis: ocular and systemic clinical features and outcomes.
Zhang, Tadross … Flynn
J Ophthalmic Inflamm Infect·May 25, 2026
This retrospective study of 50 eyes with culture-proven endogenous endophthalmitis found that 46% were fungal in origin, 61% lacked systemic symptoms at presentation, and visual outcomes remained poor despite treatment with 52% achieving ≥20/400 vision.